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Moreover, it must be noted that the induction of pulmonary alveolar adenoma or adenocarcinoma in mice by a variety of chemically dissimilar carcinogens (e.g. urethane and 4-nitro-quinoline-N-oxide) is most striking in those strains, such as A and BALB/c, which have a high spontaneous incidence of such tumours. Tumours of similar histogenesis can be induced experimentally in rats but they very rarely occur spontaneously. In terms of initiators and promoters, mice of different strains behave as though they have variable amounts of some inborn initiator which determines the response of their alveolar cells to a variety of carcinogenic promoters. Apart from known genetic factors no " initiator " as postulated has been identified.
It seemed desirable, therefore, to assay INH on animals other than mice, under comparable conditions of exposure, and at non-toxic dosage, for the major part of their lives.
MATERIAL AND METHODS
All rodents were fed on Diet No. 41 pellets. Pilot experiments showed that with our strains of C3Hf mice and BALB/c mice a single subcutaneous injection of 2 mg. or a daily oral intake of 2 mg. INH per adult mouse of about 20 g. was toxic for about a third of the animals, but was tolerated when given by gastric intubation not more frequently than twice a week, or daily in drinking water probably because in the latter case the drug was taken gradually over 24 hours.
Subcutaneous injection
Mice-Thirty male and 10 female C3Hf aged between 5-17 weeks and 23 male and 16 female BALB/c mice aged between 7-36 weeks were injected subcutaneously with 0-2 ml. of INH solution equivalent to 2 mg. per injection.
At first injections were given three times a week, but owing to heavy mortality and evidence of peripheral neuritis in the survivors, the frequency of injection was reduced. Thus those which died early in the experiment received relatively higher total dosage. The total dose va-ried somewhat between mice, because those which looked sick were not injected until they had recovered. Over a period of 8 months 56 injections were given.
Results.-No pulmonary tumours were seen in mice which died at less than 40 weeks of age. Of C3Hf mice that survived beyond this age, of 17 males only 1, which died aged 36 weeks, had a deep-seated papillary adenoma ; no pulmonary tumours occurred in 6 female survivors (Table I) . Among male BALB/c mice which survived for more than 40 weeks, 8 out of 19 had no pulmonary tumours. In the remaining 11 there were 8 with subpleural papillary adenomata, 6 with papillary adenomata at other sites, 1 with hyperplasia at subpleural and at other sites.
Among 11 females, over 40 weeks old, 3 had no pulmonary tumours. Among 8 with lung tumours, 6 had subpleural papillary adenomata at other sites and 3 had alveolar hyperplasia at other sites and 1 at subpleural and at other sites (Table II) .
Gastric intubation
Twenty-four male and 17 female BALB/c mice were given INH by gastric intubation three times a week, or less frequently if toxic effects appeared, for 40 to 45 weeks. A daily dose of 2 mg. caused some early deaths due to toxicity of the drug. Sixteen males and 11 females survived for more than 40 weeks, but all died or were killed by 65 weeks. The survival, duration of exposure and total dose of INH and site and type of tumour are shown in Table III. Results.-One subpleural and one deep-seated papillary adenoma in a male and one subpleural tumour, not confirmed histologically, and one subpleural papillary adenoma in a female were found; all others were free of pulmonary tumours, but most of them had chronic respiratory lesions, septic bronchitis, bronchopneumonia, or bronchiectasis.
It was found impossible to distinguish infected tumours from peripheral bronchiectatic abscesses on naked eye examination and only microscopic examination of serial sections revealed the true character of different lesions ( Fig. 1 and 2) .
It was felt that daily administration without instrumentation of any kind was preferable because it resembled the method of administration to human patients. Metabolic studies (Chalmers, 1965) showed that the drug was absorbed, 309 and metabolites were recovered from the urine. The above methods of assay were abandoned, therefore, in favour of daily administration of the drug in drinking water.
INH in drinking water
Thirty-six male and 14 female C3Hf and 15 male and 20 female BALB/c mice, aged 6 to 14 weeks, were given 01 I% aqueous INH solution in drinking bottles and consumed on average between 2 and 3 ml. (2 to 3 mg. INH) per mouse per day throughout their lives. All those that died naturally were examined as soon as possible after death, and even in those which showed autolytic changes it was generally possible to recognise pulmonary tumours when present. Sick mice at any age were killed, and all survivors were killed when 2 years of age, and immediately autopsied.
Re,sults.
-At approximately 2X5 mg. of INH per average 20 g. adult mouse the dosage was considered to be the highest tolerable and 8 C3Hf and 1 BALB/c mice died within 24 hours of the experiment. Thus the effective population of 50 C3Hf and 35 BALB/c was selected for tolerance.
No pulmonary tumours occurred in mice which died below 30 weeks of age and only those which survived beyond this period are considered in assessing the carcinogenic response (Tables IV and VI) . (Table VIII) . Age 113 weeks. Killed in good condition. Total dose of INH = 13-0 g. Lungs healthy apart from a 3 mm. subpleural lesion on the posterior aspect of the left lobe at the level of the 8th rib. Picro-Mallory and elastin. x 60. Section shows part of a wedge shaped subpleural area of mixed alveolar hyperplasia and early papillary adenoma, with a small focus of distended alveoli containing unidentified non-birefringent elongated foreign bodies partly phagocytosed (circled). Note abrupt transition from normal to hyperplastic epithelium and preservation of normal alveolar pattern. Slight thickening of the pleura is visible (top right). (Table IX) a period of 24 weeks, equivalent to a total dose of 680 mg. All the males were killed aged 28 to 29 weeks. Two females were found dead aged 21 weeks, and 6 were killed aged 29 weeks.
Group II. Intraperitoneal injection of INH
One male and 6 females 24 weeks old received 20 intraperitoneal injections of 0.2% INH solution over a period of 16 weeks, giving a maximum total dose of 550 mg. Two females were found dead aged 85 and 106 weeks, respectively, and the 1 male and 4 females were killed aged 77, 85, 95 (2) and 106 weeks.
Results.-No tumours were found in the lungs or in any other organ or tissue in the animals in Group I and II. Group III A small group of 4 male and 4 female rats aged 8-10 weeks were given 0.25% INH solution daily in drinking bottles throughout the experiment. A 200 g. rat consumed an average daily dose of 18 mg. INH (Table VIII) . Results. There was a high incidence of respiratory lesions; bronchitis, bronchiectasis and broncho-pneumonia were present at death in all but the youngest, but only the last surviving female aged 113 weeks showed central and subpleural alveolar hyperplasia and papillary adenoma ( Fig. 3 and 4) comparable with the lesions so described in mice (Peacock and Peacock, 1966) .
Group I V
A group of 14 males and 9 females were given INH in drinking water and food for 20 weeks by which time they showed loss of appetite and consequent loss of weight because they drank less than controls. Those that died were found to be constipated, some with the whole length of the colon distended with faeces. The INH solution was therefore withheld for a week and replaced by tap water which the rats drank avidly. Thereafter the INH solution was given on alternate weeks only, for a further 35 weeks by which time the animals had regained and maintained normal weight. However, they did not drink as much as controls and the drug was therefore mixed with the food in quantity to give the same average daily dose supplemented by tap water ad libitum.
The animals tolerated this regime well and the survivors were killed when approximately 2 years old.
Results. The course of the experiment is shown in Table IX . Only one hyperplastic and neoplastic subpleural pulmonary lesion was found. Many animals had chronic respiratory infections but there was an unexpected incidence of 5 cases of rectal prolapse, 4 of which were associated with squamous metaplasia of the glands of the terminal part of the rectum and with multifocal squamous papilloma of the anal margin (Fig. 6, 7, 8) , one showing areas of possibly early squamous carcinoma (Fig. 5) .
Further reference to these cases will be made under Discussion.
No comparable lesions were seen in 15 male and 14 female Wistar rats kept during the experimental period as controls. (Table X) .
Desert Rats (Meriones lybicus) JNH in drinking water
Seventeen males and 11 females aged 4 months were given INH daily in drinking water as a 0 25% solution throughout their lives.
Results.-The results are shown in Table XI . No lung tumours were found but in the two oldest males, killed at 128 weeks of age, there were small foci of subpleural lymphatic engorgement of the type associated in mice and rats with alveolar hyperplasia. No tumour at any site in either sex was found in 5 male and 6 female desert rats of comparable ages (all over 1 year).
Hamsters (Mesocricetus auratus) Intraperitoneal injection of INH
Three males and 2 females aged 8 weeks received 15 intraperitoneal injections of 0.10% INH in water, equivalent to 10 mg. INH per 100 g. body weight and a total dose of 90 mg.
Results.-One male died aged 51 weeks and 2 were killed at 66 and 67 weeks, (Fig. 6 ). . .. .. .. .. . Bronchopneumonia; prolapse.
Keratinising papilloma and squamous metaplasia and carcinoma of anal glands. (Fig. 7) 
DISCUSSION
Only in C3Hf mice was the incidence of lung tumours clearly increased by treatment with INH (Tables IV and V) .
In our short term groups of BALB/c mice given INH by gastric intubation the results were confused by the high incidence of unresolved septic bronchitis, bronchopneumonia and bronchiectasis associated in 2 animals with papillary adenoma.
In long term experiments there was no significant difference between the experimental and control BALB/c mice at about 2 years of age. C3Hf mice, on the other hand, with a lower spontaneous incidence of pulmonary tumours, showed a significantly increased incidence of tumours attributable to INH.
We have adopted a method of classification of lung tumours in mice based on the anatomical site of origin and histological criteria of neoplasia (Peacock and Peacock, 1966) and this method has been used also in examining the lungs of the other species of rodent.
Positive records under each heading were all confirmed, unless otherwise stated, by examination of serial sections through the macroscopically visible lesions. Often smaller lesions involving even a few cells were discovered during such examinations. No attempt has been made to enumerate the lesions of each type in this study because many lesions are obviously multicentric in origin and some are so small or so early that they might be debatable.
Despite these limitations it is obvious that INH is carcinogenic for C3Hf mice, but not obvious in the case of BALB/c mice, in our experiments. Bianciflori and Ribacchi (1962) showed that daily administration of 2 mg. of INH by gastric intubation caused pulmonary tumours in all of 38 virgin female BALB/c mice which survived for 46 weeks following the start of treatment at 8 weeks of age. Their total dosage was 502 mg. They saw no pulmonary tumours in untreated controls.
In our experiments approximately the same total dosage was given over 80-120 weeks, with similar results in BALB/c mice of both sexes, but at that age the untreated controls also had a high incidence of spontaneous tumours.
The tables show the sex, age and duration of exposure to INH, the total dose per animal and the incidence and site of origin of hyperplastic and neoplastic prolapse and anial tumours were caged together throughout their lives. Two were killed aged 78 weeks for prolapse and perineal tumours, one had a keratinised multifocal papilloma apparently originating in the anal skin (Fig. 6) ; the other had a larger keratinising squamous papilloma and early carcinoma (not illustrated) associated with squamous metaplasia of the columnar cell glands of the prolapsed rectum and anal canal (Fig. 7) . The third sister was killed aged 108 weeks in good condition and was found to have a small wart in the anal canal; histologically this was a keratinising squamous papilloma. There was a diaphragmatic hernia of part of the central lobe of the liver which showed no histological abnormality; otherwise no abnormality was found. No constipation was present in these 3 sisters at the time of death. The one male which was killed aged 61 weeks for prolapse had a squamous papilloma and early carcinoma of the anal canal (Fig. 5 ) and also had unresolved bronchopneumonia and adenosis of the bronchial epithelium and an abscess in the right maxilla. Its cage mate, killed at 96 weeks, also had bronchiectasis and a small patch of alveolar hyperplasia.
The male with anal papilloma was half-brother to the 4 sisters with similar lesions, their mothers were litter mate sisters both mated to the same litter mate brother. However, the grandparents were of heterozygous Wistar stock. The complexity of the aetiological factors in these rats is apparent. All were exposed to daily dosage of INH, all were infested with Demodex folliculorumn, and they were closely related. Constipation, a factor predisposing to prolapse, was common to most of the rats on INH when it was given in drinking water but not in the latter part of the experimental period when it was mixed with the food, and it is interesting to note the absence of macroscopic tumours in the first of the sisters killed for prolapse at 14 weeks of age. Unfortunately no sections were taken in this case. The presence of Demodex infestation of the perineal pilosebaceous glands in these 5 rats is recorded without prejudice. Unfortunately the observation was made after the death of all the experimental and control animals during histological study and consequently no contemporary control observations are available. However, one untreated female survivor from the same stock of Wistar rats was killed in good condition at 75 weeks of age and immediately examined. No lesions were found in any organ. Serial sections of skin from perineal and other sites showed general infestation of pilosebaceous follicles by Demodex folliculorum, but no inflammatory or other tissue reaction. It seems probable, therefore, that the whole stock of Wistar rats was infested though they showed no signs of dermatitis. Desert rats and hamsters showed no lesions attributable to INH. The ears of the desert rats are frequently infested by Demodex folliculorun where it does not seem to cause irritation or gross or microscopic lesions, but some years ago we observed one case of spontaneous squamous carcinoma of the external auditory meatus associated with Demodex infestation in this species. We have never found Demodex infestation in hamsters or mice. Symptomless infestation by Demodex folliculorum of the pilosebaceous follicles of facial and mammary regions occurs with undetermined frequency in man and is usually demonstrable in our experience in the neighbourhood of rodent ulcers.
Though there is insufficient evidence to justify any opinion on a possible aetiological role of the Demodex in skin cancer, it seems desirable to record its presence when observed.
